Siobhain Mulrennan

Clinical Professor, Health and Medical Sciences, Internal Medicine

Emailsiobhain.mulrennan@uwa.edu.au

The University of Western Australia (M570), 35 Stirling Highway,
6009 Perth
Australia

Source: Scopus
Calculated using citation counts from Scopus for publications in the UWA Profiles and Research Repository

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Siobhain Mulrennan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

23 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

188 Citations
8 h-Index
16 Article
6 Abstract/Meeting Abstract
3 Letter
2 Conference paper
More

Mepolizumab use in cystic fibrosis-associated allergic bronchopulmonary aspergillosis
Boyle, M., Mulrennan, S., Morey, S., Vekaria, S., Popowicz, N. & Tai, A., Jan 2021, In : Respirology Case Reports. 9, 1, e00696.
Research output: Contribution to journal › Article

Open Access
Medical information and social media in the time of COVID-19
Mulrennan, S. & Colt, H., 1 Jun 2020, In : Respirology. 25, 6, p. 578-579 2 p.
Research output: Contribution to journal › Comment/debate

Open Access
U-shaped association of vigorous physical activity with risk of metabolic syndrome in men with low lean mass, and no interaction of physical activity and serum 25-hydroxyvitamin D with metabolic syndrome risk
Yeap, B. B., Dedic, D., Budgeon, C. A., Murray, K., Knuiman, M. W., Hunter, M., Zhu, K., Cooke, B. R., Lim, E. M., Mulrennan, S., Walsh, J. P. & Green, D. J., 1 Apr 2020, In : Internal Medicine Journal. 50, 4, p. 460-469 10 p.
Research output: Contribution to journal › Article
A pragmatic application of endobronchial ultrasound-guided transbronchial needle aspiration: A single institution experience
Bailey, N., Krisnadi, Z., Kaur, R., Mulrennan, S., Phillips, M. & Slavova-Azmanova, N., 20 Aug 2019, In : BMC Pulmonary Medicine. 19, 1, 155.
Research output: Contribution to journal › Article

Open Access
1 Citation (Scopus)
CLINICAL FEATURES AND LONG-TERM OUTCOME OF PATIENTS WITH SADDLE PULMONARY EMBOLISM: EXPERIENCE FROM TWO TERTIARY CENTRES
Harryanto, H., Ho, A., Solangaarachchi, M., Kuok, Y., Moodley, Y. & Mulrennan, S., Mar 2019, In : Respirology. 24, p. 144-144 1 p.
Research output: Contribution to journal › Abstract/Meeting Abstract

2 Finished
5 Active

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis –The ASPEN Study
Mulrennan, S.
PPD PTY LTD
20/01/21 → 1/01/24
Project: Research
BEAT CF: Bayesian Evidence-Adaptive Treatment for managing Cystic Fibrosis
Mulrennan, S.
Medical Research Future Fund MRFF
1/09/20 → 31/08/23
Project: Research
A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetic Effects of ARO-ENaC in Normal Healthy Volunteers and Safety, Tolerability and Efficacy in Patients with Cystic Fibrosis
Mulrennan, S.
Novotech (Australia) Pty Limited
1/09/20 → 31/08/21
Project: Research
A phase 3b, randomized, double blind, controlled study evaluating the efficacy and safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis subjects, homozygous for F508del mutation - VX18-445-109
Mulrennan, S.
Vertex
1/10/19 → 30/09/21
Project: Research
A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects - VBX19-445-115
Mulrennan, S.
Vertex
26/09/19 → 25/09/21
Project: Research